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Epithelial Chloride Transport by 
CFTR Requires TMEM16A
Roberta Benedetto1, Jiraporn Ousingsawat1, Podchanart Wanitchakool1, Yong Zhang2, 
Michael J. Holtzman  2, Margarida Amaral  3, Jason R. Rock4, Rainer Schreiber1 &  
Karl Kunzelmann1
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is the secretory chloride/bicarbonate 
channel in airways and intestine that is activated through ATP binding and phosphorylation by protein 
kinase A, but fails to operate in cystic fibrosis (CF). TMEM16A (also known as anoctamin 1, ANO1) is 
thought to function as the Ca2+ activated secretory chloride channel independent of CFTR. Here we 
report that tissue specific knockout of the TMEM16A gene in mouse intestine and airways not only 
eliminates Ca2+-activated Cl− currents, but unexpectedly also abrogates CFTR-mediated Cl− secretion 
and completely abolishes cAMP-activated whole cell currents. The data demonstrate fundamentally 
new roles of TMEM16A in differentiated epithelial cells: TMEM16A provides a mechanism for enhanced 
ER Ca2+ store release, possibly engaging Store Operated cAMP Signaling (SOcAMPS) and activating 
Ca2+ regulated adenylyl cyclases. TMEM16A is shown to be essential for proper activation and 
membrane expression of CFTR. This intimate regulatory relationship is the cause for the functional 
overlap of CFTR and Ca2+-dependent chloride transport.
The cystic fibrosis transmembrane conductance regulator (CFTR) and the calcium-activated chloride channel 
TMEM16A (anoctamin 1) are the two major secretory anion channels in intestinal and airway epithelia and 
therefore provide the critical regulation of mucus hydration at these sites1–4. TMEM16A and a third anion chan-
nel, SLC26A9, have been shown to be upregulated and particularly relevant during airway inflammation and 
asthma5,6. TMEM16A and SLC26A9 attenuate airway inflammation in cystic fibrosis (CF)7, prevent mucus 
obstruction during airway inflammation and attenuate the intestinal obstructive phenotype in CF mice6,8. In CF, 
TMEM16A and its regulator CLCA1 have been proposed as potential drug targets to compensate for the abro-
gated CFTR function in CF patients, while in asthma it may help to solubilize excess inflammatory mucus which 
may otherwise lead to airway obstruction9,10.
Previous in vitro studies suggested a functional relationship between calcium-activated TMEM16A and 
cAMP-regulated CFTR by some unknown mechanism11–13. Inhibition of TMEM16A by activated CFTR 
was suggested, while others reported similar pharmacological and functional properties for both Ca2+ and 
cAMP-activated Cl− currents14–16. A recent study in human airway epithelial cells suggested CFTR as the 
principal chloride secretory pathway for both cAMP and purinergic; i.e. Ca2+ enhancing agonists17. Similarly, 
muscarinic stimulation was shown to activate CFTR via increase in intracellular cAMP, and both Src and Pyk2 
tyrosine kinases18. Collectively, these data suggest that CFTR may function as a chloride channel that is activated 
by both cAMP and Ca2+.
Earlier work showed that mice lacking expression of TMEM16A in the airways present with a CF-like lung 
phenotype, suggesting that TMEM16A is essential for chloride secretion and maintenance of the airway sur-
face liquid in mouse airways4,19. However, these results were obtained in conventional TMEM16A-deficient mice 
that exhibit multiple organ failures, requiring studies being performed on compromised newborn pups. We 
therefore generated mouse lines in which TMEM16A expression was selectively deleted in intestinal villus and 
crypt epithelial cells (using Vil1-Cre–TMEM16Aflox/flox mice) or ciliated airway epithelial cells (using FOXJ1-Cre–
TMEM16Aflox/flox mice). This approach allowed for the first studies of adult mice with TMEM16A deficiency and 
demonstrated that TMEM16A expression is responsible for the calcium-activated chloride anion current in the 
intestine and lower respiratory airways and is essential for CFTR function at both of these mucosal sites.
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Results
Intestinal epithelial cell knockout of TMEM16A eliminates CFTR currents. An intestinal epithelial 
cell-specific TMEM16A gene knockout mouse (Vil1-Cre–TMEM16Aflox/flox) was generated from Vil1-Cre and 
TMEM16Aflox/flox mice (Fig. S1) to determine TMEM16A function in the adult mouse intestinal epithelium. 
In contrast to reports of conventional TMEM16A-defiicent mice4,19, the Vil1-Cre–TMEM16Aflox/flox mice did 
not show any difference in birth rate or lifespan, or manifest any baseline intestinal abnormalities (includ-
ing intestinal obstruction or change in faecal water content) compared to control TMEM16A wild-type (wt) 
mice (Vil1-Cre–TMEM16Awt/wt) (Fig. S2). Micro-perfused Ussing chamber experiments were used to assess 
ion transport of colonic epithelium by determining transepithelial voltage (Vte) under open circuit conditions 
and calculating equivalent currents (Isc). Perhaps as expected, carbachol-stimulated calcium-activated anion 
transport was no longer present in colonic epithelia from Vil1-Cre–TMEM16Aflox/flox compared to Vil1-Cre–
TMEM16Awt/wt control mice (Fig. 1a,b). In addition, and rather unexpectedly, cAMP-activated anion trans-
port was also markedly attenuated in intestinal epithelia from Vil1-Cre–TMEM16Aflox/flox mice (Fig. 1c,d). This 
decrease in transport function was not accompanied by any change in the level of CFTR expression in colonic 
epithelial cells based on TMEM16A western blotting (Fig. S1d). In contrast, the pattern of CFTR expression 
in colonic epithelium of Vil1-Cre–TMEM16Aflox/flox mice was different, with clearly compromised apical CFTR 
expression (Fig. S1a).
cAMP (IBMX and forskolin) stimulation failed to expand the luminal cavity in intestinal organoids from 
Vil1-Cre–TMEM16Aflox/flox mice compared to wild-type control mice, indicating that the defect in intestinal 
cAMP-activated anion transport in Vil1-Cre–TMEM16Aflox/flox mice was accompanied by decreased secretion 
(Fig. 1e,f). Consistent with these results, both carbachol and cAMP stimulation of ion currents determined by 
whole cell patch clamping were lost in freshly isolated mouse colonic epithelial cells from Vil1-Cre–TMEM16Aflox/flox  
mice compared to wild-type control mice (Fig. 1g–r). Ca2+ and cAMP activated currents were identified by block-
ade with inhibitors for TMEM16A (CaCC-AO1) and CFTR (CFTRinh172)20,21 (Fig. 1m,o–r; Fig. 3g,h). However, 
as indicated below crosstalk of both, Ca2+ and cAMP signalling pathways may lead to a cross-inhibition by both 
inhibitors. Together, the results show that calcium-activated as well as cAMP-stimulated CFTR-dependent chlo-
ride secretion in mouse intestinal epithelial cells depends on TMEM16A expression.
Respiratory epithelial knockout of TMEM16A eliminates CFTR currents. We next examined the effect 
of TMEM16A-deficiency in respiratory airway function by generating an epithelial ciliated cell-specific knock-
out of the TMEM16A gene (FOXJ1-Cre-TMEM16Aflox/flox mice) derived from FOXJ1-Cre and TMEM16Aloxp/loxp  
mice (Figs 2 and S3a–c). TMEM16A was partially colocalized with CFTR in ciliated epithelial cells, but was 
absent in knockout airways (Fig. S3d,e). Notably, the TMEM16A antibody may have only detected larger 
expression levels. Like Vil1-Cre-TMEM16Aflox/flox mice, the FOXJ1-Cre-TMEM16Aflox/flox mice developed 
normally with birth rates and lifespans similar to wild-type control mice. Particle transport was assessed in 
isolated mouse tracheas as an index of mucociliary clearance (MC)4. It was not compromised, but unexpect-
edly even enhanced under basal conditions in tracheas from FOXJ1-Cre-TMEM16Aflox/flox mice, compared 
to wild-type control tracheas. However, stimulation by ATP or carbachol did not further enhance MC in 
FOXJ1-Cre-TMEM16Aflox/flox cells, in contrast to wild-type control cells (Fig. S2e). No mucus plugging was 
observed in the lungs of FOXJ1-Cre-TMEM16Aflox/flox mice or wild-type control mice. Experiments with 
micro-perfused Ussing chambers showed that luminal ATP- or basolateral CCH-induced voltage deflec-
tions (ΔVte) and calculated ΔIsc were both attenuated in tracheas from FOXJ1-Cre-TMEM16Aflox/flox mice 
compared to wild-type control mice (Fig. 2a–d). As observed in cells from Vil1-Cre-TMEM16Aflox/flox mice, 
also in tracheas from FOXJ1-Cre-TMEM16Aflox/flox mice cAMP activated transport was inhibited (Fig. 2e,f). 
Moreover, whole cell patch clamp experiments on primary-cultured mouse tracheal epithelial cells demon-
strated large ATP-activated Cl− currents in cells from wild-type tracheas, which were absent in cells from 
FOXJ1-Cre-TMEM16Aflox/flox tracheas, indicating that Ca2+ dependent Cl− currents in mouse respiratory epi-
thelial cells are entirely due to TMEM16A (Fig. 2g,h). cAMP activated whole cell Cl− currents were small 
but detectable in wild-type airway cells, and were significantly inhibited by CFTRinh172. In contrast, in cells 
from FOXJ1-Cre-TMEM16Aflox/flox tracheas no currents were activated by cAMP, and CFTRinh172 had no 
effects (Fig. 2i,j). Taken together, in both intestine and airways knockdown of TMEM16A strongly inhib-
ited cAMP-activated, i.e. CFTR-related Cl− transport in addition to the abolished Ca2+ dependent chloride 
secretion.
Cl− currents by CFTR and TMEM16A in human airway epithelial cells are linked. To translate 
the results obtained in mouse airways to humans, we studied cystic fibrosis bronchial epithelial (CFBE) cell lines 
engineered to stably express wt-CFTR or the most frequent mutant form F508del-CFTR, when compared to the 
parental cell line that does not express CFTR (Figs 3a and S4a)22. Although all three cell lines expressed com-
parable levels of TMEM16A (Fig. 3a, and S4a), the Ca2+-dependent whole cell currents activated by ATP were 
large in CFBE/wt-CFTR cells, but were small for CFBE/F508del-CFTR and parental cells (Fig. 3b,c). As expected 
cAMP-dependent currents were large in CFBE/wt-CFTR, but were essentially absent in CFBE/F508del-CFTR 
cells (Fig. 3d,e). Because large cAMP-dependent (CFTR) currents were paralleled by large TMEM16A currents, 
we knocked down TMEM16A gene expression in CFBE/wt-CFTR cells to see whether this affects CFTR currents 
(Fig. 3f). Strikingly, elimination of ATP-activated TMEM16A whole cell currents (Fig. 3g, upper panel), also 
abolished cAMP-activated CFTRinh172-inhibitable currents, despite expression of CFTR remained unaffected by 
TMEM16A-knockdown (Fig. 3g, lower panel, Fig. S4b). The results reproduce the functional interaction between 
TMEM16A and CFTR, and identify TMEM16A as the Ca2+ activated anion channel in human airway epithelial 
cells. There was also a considerable pharmacological overlap between CFTR and TMEM16A, as both currents 
were inhibited by the TMEM16A inhibitor AO1 and the CFTR blocker CFTRinh172 (Fig. 3h). Finally, when 
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CFBE/wt-CFTR and CFBE/F508del-CFTR cells were grown to polarized epithelia on permeable supports and 
examined in Ussing chambers, the results were analogous: Vte and Isc induced by either cAMP or ATP were large 
in CFBE/wt-CFTR epithelia, but were almost absent in CFBE/F508del-CFTR tissues. Moreover, CFTRinh172 
blocked both CFTR (cAMP) and CaCC (ATP)-induced transport (Fig. 3i–k).
Figure 1. Intestinal epithelial knockout of TMEM16A eliminates CFTR currents. (a) Original recordings of 
the transepithelial voltage Vte and the effect of carbachol (CCH, 100 µM) in colonic epithelia from mice with 
intestinal epithelial knockout of TMEM16A (Vil1-Cre–TMEM16Aflox/flox; TMEM16A−/−) and wild-type mice 
(TMEM16A+/+). (b) Summary of the calculated CCH-induced short circuit currents (ΔIsc). (c,d) Original 
recordings of Vte and summary of cAMP (IBMX 100 µM/forskolin 2 µM)-induced ΔIsc in +/+ and −/− colonic 
epithelia. (e,f) cAMP-induced secretion in intestinal organoids from +/+ and −/− intestines (upper panel) and 
summaries of luminal area increase (lower panel). (g–i) Activation of whole cell currents by CCH and inhibition 
by CaCCinhAO1 (AO1; 10 µM) in isolated intestinal epithelial cells from +/+ mice. Original recordings (g), 
individual experiments (h) and current/voltage relationships (i). (j–l) Corresponding experiments in intestinal 
epithelial cells from −/− mice. (m–o) Activation of whole cell currents by cAMP and inhibition by CFTRinh172 
(CFTRinh; 10 µM) in isolated intestinal epithelial cells from +/+ mice. (p–r) Corresponding experiments in 
intestinal epithelial cells from −/− mice. Mean ± SEM; *Significant activation by cAMP or CCH (paired t-test). 
#Significant difference between −/− and +/+ (unpaired t-test). (number of mice or cells, respectively).
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TMEM16A activates CFTR by enhancing Ca2+ store release. The present results establish that 
CFTR and TMEM16A currents are functionally linked and interdependent. To determine the mechanism 
for TMEM16A enhancement of CFTR activity, we analysed the effect of additional (exogenous) TMEM16A 
Figure 2. Respiratory epithelial knockout of TMEM16A eliminates CFTR currents. (a) Original recordings 
of the transepithelial voltage Vte and the effect of ATP (100 µM) in tracheas from FOXJ1-Cre–TMEM16Awt/wt 
(+/+) and FOXJ1-Cre–TMEM16Aflox/flox (−/−) mice. (b) Summary of the calculated ATP-induced short circuit 
currents (ΔIsc). (c,d) Original recordings of Vte and summary of CCH-induced ΔIsc in +/+ and −/− tracheas. 
(e,f) Original recordings of Vte and summary of cAMP (IBMX 100 µM/forskolin 2 µM)-induced ΔIsc in +/+ 
and −/− tracheas. (g) Original recordings of whole cell currents activated by ATP in primary-cultured tracheal 
epithelial cells from TMEM16A+/+ and TMEM16A−/− mice. Experiments were performed in the presence of 
an inhibitor of Ca2+ activated K+ channels, TRAM-34 (100 nM). (h) Corresponding current/voltage relationships 
of whole cell currents activated by ATP in TMEM16A+/+ and TMEM16A−/− cells. (i) Original recordings of 
whole cell currents activated by cAMP in primary cultured respiratory epithelial cells from TMEM16A+/+ and 
TMEM16A−/− mice. (j) Corresponding current/voltage relationships of whole cell currents activated by cAMP in 
TMEM16A+/+ and TMEM16A−/− cells. Mean ± SEM; *Significant activation by cAMP or ATP (paired t-test). 
#Significant difference between −/− and +/+ (unpaired t-test). (number of mice or cells, respectively).
www.nature.com/scientificreports/
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expression on CFTR function in CFBE/wt-CFTR cells. We found that additional TMEM16A enhanced 
ATP-activated TMEM16A currents in parental cells as expected, but in addition also enhanced cAMP-activated 
CFTR currents in CFBE/wt-CFTR and even in CFBE/F508del-CFTR cells (Fig. 4a). To determine the molecular 
Figure 3. Cl− currents by CFTR and TMEM16A in human airway epithelial cells cannot be strictly 
separated. (a) Western blot demonstrating wt-CFTR expression in CFBE/wt-CFTR cells, but not in CFBE 
parental cells. Both cells lines express similar levels of TMEM16A. (b) ATP (100 µM) -activated whole cell 
currents in CFBE parental cells and CFBE cells expressing wt-CFTR or F508del-CFTR. (c) Corresponding 
current/voltage relationships. (d) Whole cell currents activated by cAMP (100 µM IBMX/2 µM forskolin) 
in CFBE cells expressing wt-CFTR or F508del-CFTR. (e) Corresponding current/voltage relationships. 
(f) Western blot indicating suppression of TMEM16A in CFBE/wt-CFTR cells by siRNA (g) Summary 
of ATP (100 µM) -activated whole cell currents in CFBE/wt-CFTR cells treated with scrambled RNA or 
after siRNA-knockdown of TMEM16A (upper panel). Inhibition by CaCCinh-AO1 (10 µM). Summary of 
cAMP-activated whole cell currents in control (scrambled) and TMEM16A-knockdown cells, and effect 
of CFTRinh172 (10 µM). (h) Remaining currents after inhibition with CaCCinh_AO1 and CFTRinh172. 
Both blockers inhibit ATP- and cAMP-activated whole cell currents. (i) Transepithelial voltages recorded 
in polarized grown CFBE/wt-CFTR and CFBE/F508del-CFTR cells. Voltage deflections induced by cAMP 
or ATP. (j) Transepithelial voltages recorded in the presence of CFTRinh172 (10 µM). (k) Summaries of the 
corresponding calculated short circuit currents (Isc). Mean ± SEM; *Significant activation by ATP and cAMP, 
or currents inhibition by AO1 and CFTRinh, respectively (paired t-test). #Significant difference between 
scrambled and siTMEM16A or between wt-CFTR and F508del-CFTR, respectively (paired t-test). (number 
of cells).
www.nature.com/scientificreports/
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Figure 4. TMEM16A provides Ca2+ for activation of CFTR. (a) Summary of whole cell currents activated by increase 
in intracellular Ca2+ (ATP; 100 µM) and cAMP (IBMX 100 µM/forskolin 2 µM) in parental cells, CFBE/wt-CFTR 
and CFBE/F508del-CFTR cells, with or without (mock) additional expression of exogenous TMEM16A. Additional 
TMEM16A augments ATP-induced currents in all cell lines, enhances cAMP-activated currents in CFBE/wt-CFTR 
cells, and induces cAMP-activated currents in CFBE/F508del-CFTR cells (b) cAMP-activated whole cell currents in 
CFBE/wt-CFTR cells were inhibited by the Ca2+ chelator BAPTA-AM. (c,d) Mean recordings of ATP-induced rise in 
intracellular Ca2+ (Fura2) in primary airway epithelial cells from TMEM16A+/+ (black) and TMEM16A−/− (red) 
mice (upper panel). Summary of peak and plateau Ca2+ increase (lower panel). (e,f) Mean recordings of ATP-induced 
rise in intracellular Ca2+ (Fura2) in CFBE/wt-CFTR cells (upper panel) and summary of peak and plateau Ca2+, 
which were reduced after siRNA-knockout (red) of TMEM16A (lower panel). (g,h) Recordings of ATP-induced Ca2+ 
peaks in HEK293 cells expressing GCAMP2-tagged CFTR. The ATP-induced Ca2+ peaks are larger in TMEM16A 
(red) coexpressing cells (upper panel). Summaries of Ca2+ peaks in the absence or presence of cAMP (lower panel). 
(i) Western blot indicating knockdown of TMEM16A expression by siRNA. (j) Inhibition (in %) of ATP-activated 
Cl− currents by two different inhibitors of Ca2+-dependent adenylate cyclases, ST034307 (30 µM) and KH7 (10 µM). 
(k) Time courses for activation of whole cell currents by ATP (100 µM) under control conditions, in the presence of 
the ORAI-inhibitor YM58483, and in the absence of extracellular Ca2+. Mean ± SEM; *Significant activation by ATP 
or cAMP (paired t-test). #Significant difference when compared to mock, +/+, scrambled, absence of TMEM16A, or 
con, respectively (unpaired t-test). (number of cells or assays).
www.nature.com/scientificreports/
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mechanism for TMEM16A regulation of CFTR, we examined whether TMEM16A-driven release of ER store cal-
cium might be responsible since TMEM16A is reported to enhance ER calcium store release23–25. This mechanism 
may cause CFTR activation in response to stimulation of purinergic and other phospholipase C coupled recep-
tors17,18. We found that activation of wt-CFTR was markedly decreased when Ca2+ was chelated by BAPTA-AM 
(Fig. 4b). Moreover, release of Ca2+ from the ER store (peak) was significantly reduced in tracheal epithelial cells 
from FOXJ1-Cre-TMEM16Aflox/flox mice (Fig. 4c,d). Correspondingly, ATP-induced Ca2+ store release was inhib-
ited with siRNA-mediated knockdown of TMEM16A in airway epithelial cells (Fig. 4e,f). Notably, after knock-
down of TMEM16A, a whole cell current could only be activated by cAMP in the presence of the Ca2+ ionophore 
ionomycin, confirming the role of Ca2+ and/or ER store release for activation of CFTR (Fig. S4c,d). To measure 
Ca2+ signals in close proximity of CFTR, the Ca2+ sensor GCAMP6 was fused to the C-terminus of CFTR and 
was expressed in HEK293 cells. TMEM16A enhanced ATP-stimulated Ca2+ release under control conditions and 
in the presence of cAMP (Fig. 4g,h).
Role of Ca2+ regulated adenylate cyclases. Enhanced Ca2+ store release in the presence of TMEM16A 
may support activation of CFTR through Ca2+ dependent adenylate cyclases17,26. In support of this, we found 
that the IP3 receptor inhibitor xestospongin C markedly inhibited activation of CFTR by IBMX and forskolin 
(Fig. S4e), while the TMEM16A inhibitor CaCCinhAO1 (AO1) blocked basal and ATP-induced Ca2+ increase 
(Fig. S4f). AO1 also blocked cAMP-induced fluid secretion in organoids from T84 intestinal epithelial cells 
(Fig. S4g,h). Moreover, ST034307 and KH7, both inhibitors of Ca2+ dependent adenylate cyclases, potently 
inhibited ATP-activated Cl− currents in CFBE/wt-CFTR cells (Fig. 4j). Because TMEM16A enhances ER Ca2+ 
store release, it is possible that compartmentalized increase in intracellular cAMP is induced by a mechanism 
recently identified as store operated cAMP signaling (SOcAMPs)27. SOcAMPs, i.e. increase of cAMP by ER 
store emptying, was shown to contribute to Ca2+-dependent activation of Cl− secretion in T84 colonic epithelial 
cells28. Ca2+-refill of ER stores, was shown to terminate SOcAMPs, and occurs through store operated Ca2+ entry 
(SOCE) via ORAI channels. Remarkably, the ORAI channel blocker YM58483 or Ca2+ removal caused prolonged 
activation of Cl− currents activated by ATP, which strongly suggests a contribution of SOcAMPs to activation of 
Cl− secretion (Fig. 4k).
Control of CFTR membrane expression by TMEM16A. To further define the mechanisms for reg-
ulation of CFTR by TMEM16A, we examined membrane expression of CFTR. The results suggested a cellu-
lar mislocalization of CFTR in TMEM16A knockout tissues (Fig. S1a,b). We quantified the amount of plasma 
membrane CFTR in CFBE cells by chemiluminescence, using an extracellular FLAG epitope. Very little back-
ground luminescence was found in non-expressing parental cells (con), while a robust signal was detected in 
CFBE/wt-CFTR-FLAG cells (Fig. 5a). siRNA knockdown of TMEM16A (si16A) lowered membrane expression 
of CFTR (Fig. 5a), while additional expression of TMEM16A further enhanced luminescence (Fig. 5b). Cellular 
distribution of CFTR was analysed in CFBE cells in the presence or absence of TMEM16A. Membrane and cyto-
solic expression were quantified by analysing fluorescence intensities in the regions of interests (ROI) and are 
shown as proportions of membrane versus cytoplasmic fluorescence. CFTR was detected either by cherry fluo-
rescence (Cherry-CFTR) in live imaging (Fig. 5c,d), or by using an anti-CFTR antibody in fixed cells (Fig. 5e,f). 
Both methods supplied comparable results and showed a shift of CFTR from cell membrane towards a cytosolic 
perinuclear localization. Using cell membrane surface biotinylation, we found membrane expression of CFTR 
and TMEM16A in CFBE/wt-CFTR cells, while neither CFTR nor TMEM16A could be biotinylated in CFBE/
F508del-CFTR cells (Fig. 5g). Knockdown of TMEM16A in CFBE/wt-CFTR cells attenuated membrane expres-
sion of CFTR (Fig. 5h).
Molecular interaction of CFTR and TMEM16A and a possible role of PDZ-interacting motifs. 
The present results show a functional interaction of CFTR and TMEM16A. Both proteins may therefore be 
colocalized in a functional compartment or may even physically interact, possibly through adapter proteins like 
post-synaptic density protein/Drosophila disc large tumour suppressor/zonula occludens (PDZ) proteins13. In 
support of this, we found that wt-CFTR and F508del-CFTR could be coimmunoprecipitated with TMEM16A in 
CFBE cells (Fig. 6a,b). Notably, TMEM16A pulled down the fully glycosylated form of wt-CFTR (band C), and 
the core glycosylated form of F508del-CFTR (band B). Coimmunoprecipitation was not observed for wt-CFTR 
and the TMEM16A-paralogue TMEM16F (Fig. 6c,d). Molecular interaction may require the PDZ-interacting 
motifs present at C-terminus of CFTR and TMEM16A29,30. In support of this we found that deletion of 
PDZ-interacting motifs in either CFTR or TMEM16A reduced membrane expression of each protein (Fig. S5a,b). 
Membrane expression of both protein was further inhibited by simultaneous deletion of both PDZ-interacting 
motifs (Fig S5c). Taken together, control of CFTR through TMEM16A appears largely Ca2+ dependent, which 
also affects membrane expression of CFTR and may require anchoring of these proteins in a functional compart-
ment by the help of PDZ proteins.
Discussion
We demonstrate a complete absence of cAMP-activated Cl− transport and a lack of Ca2+-dependent Cl− secretion 
in large intestine and trachea from adult conditional TMEM16A knockout mice. A disturbed cAMP-dependent 
transport was not found in airways of conventional TMEM16A knockout pups4,19, confirming the somewhat 
different physiology of neonatal vs. adult airways31. Somewhat surprising the complete absence of Cl− currents 
in TMEM16A knockout tissues did not cause any overt phenotype. Mouse airways lacking TMEM16A did not 
show any mucus accumulation, which may support the concept that airway Na+ transport is physiologically more 
relevant than Cl− secretion in mouse airways31. The data show that most (Ca2+ and cAMP-dependent) murine 
www.nature.com/scientificreports/
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airway Cl− secretion depends on TMEM16A, with little contribution of CFTR16,31. This is somewhat surprising 
since TMEM16A is expressed at very low levels in (noninflamed) murine airways5,32.
Ruffin and coworkers found reduced TMEM16A-currents in mouse and human CF bronchial epithelium33. 
Our data obtained in human CFBE cells demonstrate a pronounced inter-dependence between CFTR and 
TMEM16A, in terms of membrane expression as well as activation of ion currents (Figs 4 and 5). Moreover, we 
were not able to discriminate clearly between CFTR and TMEM16A current based on ion channel inhibitors. 
The data demonstrate a remarkable overlap of cAMP and Ca2+-dependent signaling and are in line with stud-
ies reporting Ca2+-activated secretion through CFTR17,18,26,34 and cAMP-depending Ca2+ signaling controlling 
CFTR-mediated serous cell fluid secretion in porcine and human airways35.
Although ATP might be released during activation of CFTR and may activate P2Y2 receptors, this is unlikely 
to explain the present results, as activation of CFTR was not inhibited by the P2Y2 blocker suramin (100 µM), or 
by hydrolyzing extracellular ATP with apyrase (2 U/ml) (data not shown). In fact the present data demonstrate 
a mechanism through which TMEM16A facilitates local Ca2+ signals that are required for activation of apical 
CFTR (and probably basolateral K+ channels)23–25. Because TMEM16A facilitates ER Ca2+ store release, it may 
induce store-operated cAMP signaling27, which has been shown to control Ca2+ activated Cl- secretion in T84 
Figure 5. TMEM16A enhances membrane expression of CFTR. (a,b) Membrane expression of CFTR 
detected by chemiluminescence in CFBE/wt-CFTR cells expressing CFTR containing a FLAG tag in the 
first extracellular loop and a N-terminal cherry tag. Cells were exposed to a primary FLAG antibody (Sigma 
Taufkirchen, Germany, # F3165) and a secondary peroxidase-conjugated antibody. Luminescence was detected 
in CFBE/wt-CFTR cells but not in control parental cells (con). siRNA-knockdown of endogenous TMEM16A 
reduced chemiluminescence in CFBE/wt-CFTR cells (a), while additional expression of exogenous TMEM16A 
enhanced chemiluminescence (b). Very little background chemiluminescence was observed in the absence of 
CFTR (con). Mean ± SEM, (n) number of assays. #Significant difference when compared to mock (unpaired 
t-test). (c,d) Life imaging of cherry-CFTR in CFBE/wt-CFTR cells with and without siRNA-knockdown of 
TMEM16A, as detected by cherry fluorescence. Summary of fluorescence intensity ratios (plasma membrane/
cytosolic fluorescence) indicating redistribution of the fluorescence towards cytoplasm by siRNA-TMEM16A. 
(e,f) Antibody-staining of CFTR in CFBE/wt-CFTR cells with and without siRNA-knockdown of TMEM16A. 
Summary of fluorescence intensity ratios (plasma membrane/cytosolic fluorescence) indicating redistribution 
of the fluorescence towards cytoplasm by siRNA-TMEM16A. (g) Membrane biotinylation of CFBE/wt-CFTR 
and CFBE/F508del-CFTR cells, and detection of membrane and cytosolic fractions of CFTR and TMEM16A 
using Western blot. (h) Effect of TMEM16A-knockdown on biotinylation (membrane expression) of CFTR 
and TMEM16A. Mean ± SEM; #Significant difference when compared to scrambled (paired t-test). (number of 
cells). Assays were performed in triplicates.
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colonic epithelial cells28 (Fig. 4j). Moreover, further evidence is provided for a central role of Ca2+ activated ade-
nylate cyclases17 (Fig. 4k).
In contrast to mouse airways expression of CFTR is pronounced in mouse large intestine, where it was found 
to be fully dependent on the presence of TMEM16A. Intestinal knockout of TMEM16A eliminated cAMP and 
Ca2+ activated Cl− currents in colonic epithelial cells, again without causing intestinal obstructions. This is 
explained by the fact that cAMP-activated Cl− currents were still present in the jejunum. Jejunal epithelial cells do 
not express TMEM16A and do not produce Ca2+ dependent, i.e. CCH induced Cl− currents (Fig. S6)31. Jejunal 
epithelial cells obviously do not require TMEM16A for activation or membrane insertion of CFTR, which may 
suggest the role of another TMEM16 protein. Noteworthy, cAMP-activated currents were found to be reduced 
in jejunal epithelial cells from TMEM16K−/− mice36. Our results also explain Ca2+ dependent Cl− and HCO3− 
transport by CFTR in mouse intestine and other tissues37–40.
The present data suggest that TMEM16A is required for proper expression of CFTR in the plasma mem-
brane (Fig. 5, Figs S1 and 3). Interaction of TMEM16A and CFTR in a functional signaling compartment at the 
plasma membrane may require the help of PDZ-proteins41 (Fig. S5c–f). TMEM16A has been shown to interact 
with IP3 receptors in a functional compartment also containing G-protein coupled receptors25,42. The present 
data add CFTR to such a compartment as it may be colocalized and interact directly or through PDZ proteins 
with TMEM16A. Due to the functional interaction of both proteins and cAMP/Ca2+-crosstalk, inhibitors for 
TMEM16A (e.g. CaCC-AO1) and CFTR (e.g. CFTRinh172) may be of limited use to dissect signalling pathways 
and the contribution of each channel to Cl− transport in highly differentiated tissues17,43.
Methods
Animals, cells, isolation of crypts. All animal experiments were approved by the local ethics commit-
tee of the Government of Unterfranken/Würzburg (AZ: 55.2-2532-2-328) and were conducted according to 
the guidelines of the American Physiologic Society and the German law for the welfare of animals. Generation 
of Vil1-Cre-TMEM16Aflox/flox mice and isolation of intestinal epithelial cells have been described earlier44. 
Knockout of TMEM16A in mouse airways way achieved by crossbreeding Vil1-Cre-TMEM16Aflox/flox mice 
with FOXJ1-Cre transgenic mice generated as described previously45. Generation and culture of human cystic 
fibrosis bronchial epithelial cell lines (CFBE) is also described in previous reports22,46. CFBE cells have been 
originally generated by Dr. D.C.Gruenert (Cardiovascular Research Institute, UCSF, San Francisco, USA) in 
accordance with the local guidelines and regulations. Cells were grown in minimum essential medium sup-
plemented with 2 mM glutamine and 2.5 µg/ml puromycin. For Ussing chamber measurements, the cells were 
grown on permeable supports (Corning® Costar® Snapwell™, Life Science, Tewksbury, MA). Respiratory epi-
thelial cells were isolated from mice as described47 and were grown in AECGM plus supplement (Promocell, 
Heidelberg, Germany) that contained bovine pituitary extract 13 mg/ml, EGF 10 ng/ml, epinephrine 0.5 μg/
ml, hydrocortisone 0.5 μg/ml, retinoic acid 0.1 ng/ml, transferrin 10 μg/ml, and triiodo-l-thyroxine 6.7 ng/ml. 
Media were further supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 3 μg/ml fungizone, 50 μg/
ml chloramphenicol, 0.1 mg/ml kanamycin. All media were supplemented with 10% fetal calf serum. Cells were 
Figure 6. Molecular interaction of TMEM16A and CFTR. (a,b) Coimmunoprecipitation of CFTR and 
TMEM16A overexpressed in HEK293 cells. CFTR was pulled down by anti-CFTR antibody (Alomone labs, # 
ACL-006), while TMEM16A was pulled down by mouse monoclonal TMEM16A-antibody (Geneway GWB-
MP178G). Both wt-CFTR and F508del-CFTR were found to interact with TMEM16A. Assays were performed 
in triplicates. (c,d) No coimmunoprecipitation was detected for CFTR and TMEM16F when experiments were 
performed under identical conditions using an TMEM16F antibody (Davids technology, Regensburg). White 
lines in the right blot indicate that lanes for unbound protein present on the same gel, have been relocated. 
Mean +/− SEM; #Indicates significant difference (p < 0.05; unpaired t-test). (number of experiments).
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incubated in 5% CO2 at pH 7.4. siRNA for hTMEM16A was transfected into CFBE cells using standard methods 
(Lipofectamine, Invitrogen, Darmstadt, Germany). Cells were studied 48 hrs after transfection. cDNAs and RT-PCR. 
For semi-quantitative RT-PCR, total RNA from mouse tracheal epithelial cells, crypts from mouse jejunum, prox-
imal and distal colon and CFBE cells were isolated using NucleoSpin RNA II columns (Macherey-Nagel, Düren, 
Germany). Total RNA (1µg/50µl reaction) was reverse-transcribed using random primer (Promega, Mannheim, 
Germany) and M-MLV Reverse Transcriptase RNase H Minus (Promega, Mannheim, Germany). Each RT-PCR reac-
tion contained sense and antisense primer (0.5 µM, see supplementary table 1), 0.5 µl cDNA and GoTaq Polymerase 
(Promega, Mannheim, Germany). After 2 min at 95 °C cDNA was amplified 30 cycles for 30 s at 95 °C, 30 s at 57 °C 
and 1 min at 72 °C. PCR products were visualized by loading on peqGREEN (Peqlab,VWR, Germany) containing 
agarose gels and analysed using Meta Morph Vers. 6.2 (Molecular Devices, USA). Human and mouse Primers for 
RT-PCR were (5′-3′, s-as): hTMEM16A CGACTACGTGTACATTTTCCG, GATTCCGATGTCTTTGGCTC; CFTR 
CATCTTTGGTGTTTCCTATG, GGAGTCTTTTGCACAATGG; mTMEM16A GTGACAAGACCTGCAGCTAC, 
GCTGCAGCTGTGGAGATTC; mCFTR GAATCCCCAGCTTATCCACG, CTTCACCATCATCTTCCCTAG; 
GAPDH GTATTGGGCGCCTGGTCAC, CTCCTGGAAGATGGTGATGG.
Ussing chamber experiments. Isolated tracheas were put into ice cold bath solution containing (in mM/l) 
145 NaCl, 0.4 KH2PO4, 1.6 K2HPO, 4.6 D-glucose, 1 MgCl2 1.3 Ca2+ gluconate; pH 7.4). After isolation of 
tracheas connective tissue was removed. Tissues were mounted into an Ussing chamber with a circular aper-
ture of 0.785 mm2. Luminal and basolateral sides of the epithelium were perfused continuously at a rate of 5 
ml/min. Luminal and basolateral solutions were heated to 37 °C, using a water jacket. Experiments were car-
ried out under open-circuit conditions. Data were collected continuously using PowerLab (AD Instruments, 
Spechbach, Germany). Values for transepithelial voltages (Vte) were referred to the serosal side of the epithelium. 
Transepithelial resistances (Rte) were determined by applying short (1s) current pulses (ΔI = 0.5 µA). Rte and 
equivalent short circuit currents (Isc) were calculated according to Ohm’s law (Rte = ΔVte/ΔI, Isc = Vte/Rte).
Intestinal organoids. The protocol for the small intestinal organoids isolation and culture was adopted 
from48. In brief crypts from the small intestine were isolated in Ca2+ free chelating buffer, and the crypts pellet was 
resuspended in Advanced DMDM/F12 (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 2mM 
glutathione, 100 U/ml penicillin, 100 μg/ml streptomycin, 10mM Hepes and mixed with ice- cold MatrigelTM 
(Corning® Matrigel® Matrix, Life Sciences, Tewksbury, MA). The MatrigelTM was overlayed with basal minigut 
media supplemented with Noggin and recombinant Rspo-1 (PeproTech, Hamburg, Germany).
Patch Clamping. Primary-culture of mouse tracheal epithelial cells and CFBE cells were grown on coated 
glass cover slips for patch clamp experiments. Isolated intestinal crypts were immobilized on polylysine coated 
glass cover slips. If not indicated otherwise, patch pipettes were filled with a cytosolic-like solution containing in 
mM: KCl 30, K-gluconate 95, NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, Ca -gluconate 0.758, MgCl2 1.03, D - glucose 
5, ATP 3, pH 7.2. The Ca2+ activity was 0.1 µM. Coverslips were mounted in a perfused bath chamber on the stage 
of an inverted microscope (IM35, Zeiss) and kept at 37 °C. Transfected cells were identified by cotransfection 
of pIRES and antibody bound beads (Sigma Taufkirchen, Germany). The bath was perfused continuously with 
Ringer solution at a rate of 8 ml/min. Patch clamp experiments were performed in the fast whole cell configu-
ration. Patch pipettes had an input resistance of 2–4 MΩ when filled with cytosolic like solution. Currents were 
corrected for serial resistance. The access conductance was monitored continuously and was 60–140 nS. Currents 
(voltage clamp) and voltages (current clamp) were recorded using a patch clamp amplifier (EPC 7, List Medical 
Electronics, Darmstadt, Germany), the LIH1600 interface and PULSE software (HEKA, Lambrecht, Germany) 
as well as Chart software (AD Instruments, Spechbach, Germany). Data were stored continuously on a computer 
hard disc and analyzed using PULSE software. In regular intervals, membrane voltage (Vc) was clamped in steps 
of 20 mV from −100 to +100 mV from a holding voltage of −100 mV. Current density was calculated by dividing 
whole cell currents by cell capacitance.
Measurement of [Ca2+]i. The plasma membrane bound calcium sensor GCaMP6 was fused to the 
N-terminus of CFTR. HEK293 cells grown on coated glass cover slips were transfected with GCaMP6-CFTR, 
and were mounted in a perfusion chamber 72 hrs after transfection. Cells were perfused with ringer solution at 
a rate of 8 ml/min at 37 °C. Cell fluorescence was measured continuously with an inverted microscope Axiovert 
S100 (Zeiss) using a x40 objective (Fluar 40x/1.3 Oil, Zeiss) and a high speed polychromator system (VisiChrome, 
Visitron, Puchheim, Germany). GCaMP6-CFTR was excited at 485 nm and 405 nm. Emission was recorded 
between 520 and 550 nm using a CCD-camera (CoolSnap HQ, Visitron). Control of experiments, imaging acqui-
sition, and data analysis were done with the software package Meta-Fluor (Universal imaging, New York, USA). 
Alternatively, cells were loaded with Fura2 and intracellular Ca2+ concentrations were determined as described 
earlier49.
Western Blotting, COIP, biotinylation. Protein was isolated from parental CFBE cells and from CFBE 
cells expressing wt-CFTR or F508del-CFTR using a sample buffer containing 50 mM Tris-HCl, 150 mM NaCl, 
50 mM Tris, 100 mM dithiothreitol, 1% Nonidet P-40, 0.5% deoxycholate sodium, and 1% protease inhibitor 
mixture (Sigma, Taufkirchen, Germany). For co-immunoprecipitation CFBE cells (wt and dF508) were collected 
and lysed in 0.5% CHAPs lysis buffer containing 1X protease inhibitor cocktail. Protein (500 µg) was incubated 
with 6 μg of antibody (North American CFF, #596) and pre-cleaned protein G agarose (60 µl) on a rotator at 4 °C 
overnight. Afterward, beads were centrifuged and washed three times with 0.5% CHAPs lysis buffer contain-
ing 1X protease inhibitor cocktail. The Immunocomplexes were eluted by 2x sample buffer. For biotinylation 
CFBE cells (90–100% confluent) in T75 cm2 flasks were washed twice with ice-cold PBS (Ca2+/Mg2+), followed 
by incubation with Sulfo-NHS-SS-Biotin (Thermo Scientific, Waltham, MA USA) at 4 °C for 30 min according to 
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the manufacturer’s instructions. Cells were lysed and homogenized in lysis buffer containing complete protease 
inhibitor cocktail (Roche, Penzberg, Germany) on ice for 30 minutes and centrifuged at 10,000g at 4 °C for 2 min. 
Biotin labelled surface proteins were captured on neutravidin agarose resin (Thermo Scientific, Waltham, MA 
USA) at room temperature for 1 h. The resins were washed 5 times with wash buffer containing protease inhibitor. 
Proteins bound to the resin were eluted with SDS PAGE sample buffer, and analysed by western blotting. Sample 
was separated by 8.5% SDS-PAGE and transferred to PVDF membrane (GE Healthcare, Munich, Germany). 
The membrane was blocked with 5% NFM/TBST or 5% NFM/PBST at RT for 1 h and incubated overnight 4 °C 
with rabbit polyclonal anti-TMEM16A AB (1:1000, 1% NFM/TBST), mouse monoclonal anti-CFTR AB (1:500, 
3% NFM/PBST), rabbit polyclonal anti-Na+/K+-ATPase α AB (1:1000, 1% NFM/TBST) or mouse monoclo-
nal anti β-actin AB (5% NFM/PBST). Subsequently, the membrane was incubated with HRP-conjugated don-
key anti-rabbit or goat-anti mouse IgG at RT for 2 h. Immunoreactive signals were visualized using supersignal 
chemiluminescence substrate detection kit (Pierce Biotechonology, Rockford, USA).
Chemiluminescence. CFBE wtCFTR and F508del-CFTR were tagged with an extracellular FLAG epitope 
and stably expression in CFBE cells using a doxycycline-inducible gene expression system. Surface CFTR expres-
sion was detected using monoclonal anti-FLAG M2-Peroxidase (Sigma, Taufkirchen, Germany) after 48 hr 
of doxycycline application. Cells were fixed in 4% paraformaldehyde, blocked in 5% BSA and incubated with 
anti-FLAG M2-Peroxidase (1:1,000). Chemiluminescene was detected using a SuperSignal West Pico chemilumi-
nescence substrate (Thermo Scientific, Darmstadt Germany) and measured using plate reader NOVOstar (BMG 
Labtach, Offenburg, Germany).
Immunocytochemistry. Mouse intestine, lungs and trachea were fixed by perfusion with 4% paraform-
aldehyde (PFA) and post-fixed in 0.5 mol/l sucrose, 4% PFA solution. Cryosections of 5 μm were incubated in 
0.1% SDS for 5 min, washed with PBS, and blocked with 5% bovine serum albumin (BSA) and 0.04% Triton 
X-100 in PBS for 30 min. Sections were incubated with primary antibodies (Alomone Labs, #ACL-006) in 
0.5% BSA and 0.04% Triton X-100 overnight at 4 °C and with Alexa Fluor 488 labeled donkey anti rabbit IgG 
(Invitrogen). Sections were counterstained with Hoe33342 (0.1 μg/ml PBS, Aplichem, Darmstadt, Germany). 
Immunofluorescence was detected using an Axiovert 200 microscope equipped with ApoTome and AxioVision 
(Zeiss, Germany). CFBE cells were grown on glass coverslips and fixed for 10 min with 4% (w/v) PFA at room 
temperature. After washing, the cells were permeabilized and blocked with 2% (w/v, PBS) bovine serum albumin 
and 0.04% (w/v, PBS) Triton-X-100 and incubated with primary anti-CFTR rabbit antibody (1:100, Alomone labs, 
# ACL-006) and anti-TMEM16A rabbit antibody (1:100, Geneway GWB-MP178G) over night at 4 °C. Binding 
of the primary antibody was visualized by incubation with a secondary antibody conjugated with Alexa 488 (Life 
Technologies, A-21206). Nuclei were stained with Hoe33342 (0.1 μg/ml PBS, Aplichem, Darmstadt, Germany). 
Cells were mounted on glass slides with fluorescent mounting medium (DAKO Cytomation, Hamburg, Germany) 
and examined with an ApoTome Axiovert 200 M fluorescence microscope (Zeiss, Göttingen, Germany).
Materials and statistical analysis. All animal experiments were approved by local authorities and were 
conducted according to the guidelines of the American Physiological Society and the German law for welfare 
of animals. All compounds used were of highest available grade of purity. Data are reported as mean ± SEM. 
Student’s t-test (for paired or unpaired samples as appropriate) or ANOVA were used for statistical analysis. A 
p-value < 0.05 was accepted as significant difference.
All methods were carried out in accordance with guidelines and regulation. All experimental protocols were 
approved by the University of Regensburg and Government of Unterfranken. The senior author confirms that 
informed consent was obtained from all subjects.
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